S1 E8 | Life of Her Mind

Dr. Stephanie Poindexter is a biological anthropologist at the University of Buffalo specializing in primatology. Doctor Poindexter conducts field, lab, and desk-based research into how primates use and navigate their habitats. More specifically, Doctor Poindexter investigates primate movement, morphology, and cognition. Of particular interest is the slow loris. Dr. Poindexter investigates how the ... . . .

S1 E7 | Life of Her Mind

Kinesiology Professor Shilo Nelson’s story highlights the important point that there is no one correct way to approach a career in STEM. Our conversation covers a range of topics, including the following:   Prof. Nelson’s experience in the United States Air Force;   How Prof. Nelson parlayed her discipline and physical fitness into a stint as a Seattle Sea Hawks ... . . .

S1 E6 | Life of Her Mind

Tomi Akingbade is the founder of the Black Women in Science Network and a Ph.D. student in Neurochemistry at the University of Cambridge. Tomi’s scientific research centers on the inflammatory mechanisms of aggregates in Alzheimer’s disease.  Interested in science since childhood, Tomi founded the Black Women in Science Network as a response to the lack of frank conversations ... . . .

S1 E5 | Life of Her Mind

Groundbreaking neurobiologist, Dr. Gina Turrigiano heads up the Turrigiano Lab in Brandeis University’s Biology Department. Dr. Turrigiano’s work focuses on brain plasticity. Our conversation covered a wide range of topics, including the following:    How Dr. Turrigiano and her husband, electrophysiologist, Dr. Sasha Nelson, navigated the challenges involved in ... . . .

Dr. Joshua Leisring - Associate Professor of Clinical Medicine Ohio State University

Primary aldosteronism (PA), once considered a rare secondary cause of resistant hypertension and hypokalemia, is now recognized as a highly prevalent and frequently underdiagnosed syndrome affecting patients across the full spectrum of blood pressure, most without hypokalemia. Despite the availability of effective targeted therapies, screening rates remain low, and most at-risk individuals are ...

APR 10, 2026 12:00 PM PDT